- Home
- PFO vs ALEC Comparison
PFO vs ALEC Comparison
Compare PFO & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- ALEC
- Stock Information
- Founded
- PFO 1991
- ALEC 2013
- Country
- PFO United States
- ALEC United States
- Employees
- PFO N/A
- ALEC N/A
- Industry
- PFO Finance Companies
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PFO Finance
- ALEC Health Care
- Exchange
- PFO Nasdaq
- ALEC Nasdaq
- Market Cap
- PFO 116.6M
- ALEC 124.0M
- IPO Year
- PFO N/A
- ALEC 2019
- Fundamental
- Price
- PFO $8.98
- ALEC $1.33
- Analyst Decision
- PFO
- ALEC Buy
- Analyst Count
- PFO 0
- ALEC 7
- Target Price
- PFO N/A
- ALEC $4.70
- AVG Volume (30 Days)
- PFO 31.8K
- ALEC 1.2M
- Earning Date
- PFO 01-01-0001
- ALEC 05-08-2025
- Dividend Yield
- PFO 6.51%
- ALEC N/A
- EPS Growth
- PFO N/A
- ALEC N/A
- EPS
- PFO N/A
- ALEC N/A
- Revenue
- PFO N/A
- ALEC $88,339,000.00
- Revenue This Year
- PFO N/A
- ALEC N/A
- Revenue Next Year
- PFO N/A
- ALEC $392.45
- P/E Ratio
- PFO N/A
- ALEC N/A
- Revenue Growth
- PFO N/A
- ALEC N/A
- 52 Week Low
- PFO $6.90
- ALEC $0.87
- 52 Week High
- PFO $8.51
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- PFO 54.41
- ALEC 55.51
- Support Level
- PFO $8.92
- ALEC $1.01
- Resistance Level
- PFO $9.07
- ALEC $1.46
- Average True Range (ATR)
- PFO 0.11
- ALEC 0.12
- MACD
- PFO 0.00
- ALEC 0.02
- Stochastic Oscillator
- PFO 50.00
- ALEC 71.11
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.